Please select from the following links to find out more helpful information about FLOMAX:
- FLOMAX Efficacy
- Screen your patients for BPH with this simple tool
- Help your patients get free information and support
with the Matter of Fact™ basics.
Important Safety Information
FLOMAX is indicated to treat the signs and symptoms of benign prostatic hyperplasia (BPH). FLOMAX is not indicated to treat hypertension. As with other alpha-adrenergic blocking agents, there is a potential risk of syncope. Patients beginning treatment with FLOMAX should be cautioned to avoid driving or hazardous tasks for 12 hours after their first dose or increase in dose should syncope occur. The most common side effects are dizziness, abnormal ejaculation, and rhinitis.
Caution should be exercised with concomitant administration of warfarin and FLOMAX. In addition, FLOMAX should be used with caution in combination with cimetidine, particularly at doses higher than 0.4 mg. FLOMAX is contraindicated in patients known to be hypersensitive to tamsulosin HCl or any component of FLOMAX.
Before prescribing FLOMAX, please see the full Prescribing Information.
1. IMS Health, National Disease and Therapeutic Index (NDTI™), IMS Health, National Prescription Audit (NPA), 2001 - December 2002 and IMS Health, Next Generation Prescription Services (NGPS), 2003 - May 2006, using customized BPH diagnosis and factored prescriptions.
